Comments on "Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines"

ESMO Open. 2023 Jun;8(3):101212. doi: 10.1016/j.esmoop.2023.101212. Epub 2023 Apr 11.

¹ Pharmacy Department, Catalan Institute of Oncology, Barcelona; School of Health Sciences Blanquerna, University Ramon Llull, Barcelona. Electronic address: [email protected].
² Pharmacy Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona.
³ Oncology Department, ICO-Badalona, Catalan Institute of Oncology, Barcelona, Spain; B-ARGO Group, IGTP, Badalona, Spain.
⁴ Pharmacy Department, Catalan Institute of Oncology, Barcelona; School of Health Sciences Blanquerna, University Ramon Llull, Barcelona.

No abstract available

Publication types